About
We conduct personalized diagnoses using complementary platforms such as Multiplex Blot, POCT, and m-Health. These platforms have been commercialized based on the convergence of bio, nano, and IT technologies. Over the past 10 years, our goal has been to enhance the mobile care system, enabling disease prediction and prevention, diagnosis, customized prescription, and post-treatment monitoring. Our vision is to become a global leader in in vitro diagnostic total platforms, providing accessible solutions for everyone.
Technologies
Nginx
Mobile Friendly
Deel
AI
Keywords
allergy
femtech
automation
diagnostic
diagnosis
poct
medical equipment manufacturing
biotechnology
serum-free antibody production
medical devices
diagnostic reagent
fluorescence detection
trf (time-resolved fluorescence)
ige detection
low power micro analysis
mobile health
services
allergen-specific igg
multiplex testing
cosmetics diagnostics
allergy testing
bio/nano platform
fluorescence particle photo-bleaching
digital test technology
poct analyzer
multiplex immunoassay
fluorescence analysis
health supplements
nanoparticle-based diagnostics
serum-free culture
Company Information
-
Employees 150
-
Founded 2011
-
Annual Revenue $6844000
Location
Daejeon, Daejeon, South Korea
